Clinical Trial

Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty

Study acronym: PENGIT
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this clinical trial is to compare the analgesic effect of pericapsular nerve block (PENG) with intrathecal morphine in patients scheduled for total hip replacement surgery. The main question to be answered is whether the PENG block is equivalent to intrathecal morphine in reducing postoperative pain. Participants will be randomised into two groups. Patients assigned to the PENG group will receive spinal anaesthesia with local anaesthetic (isobaric bupivacaine) alone and a PENG block. Patients assigned to the intrathecal morphine (ITM) group will receive spinal anaesthesia with a mixture of local anaesthetic (isobaric bupivacaine) and morphine (100 mcg) and a sham PENG block to ensure patient blinding.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-12.
Status change: Not Yet Recruiting → Recruiting 2024-08-20
Trial Details
NCT Number NCT06317870
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Conditions Analgesia, Hip Arthropathy, Post Operative Pain
Enrollment 80 participants
Start Date 2024-09-10
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-22